Who invested in Kezar Life Sciences

3 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$85Mraised across 3 rounds since 2015, from 3 sources

$23MSeries A$50MSeries B$12MRound

Latest round: Round, $12MOct 2022
Biggest round: $50MSeries B · Jul 2017
Investors: 11

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152016201720182019202020212022

$23MSeries A$50MSeries B$12MRound

First round: Series A, $23M
Biggest round: $50M
Usual gap between rounds: 5.2 years

The rounds

Oct 2022
Round$12M3 returning
Source recorded
Jul 2017
Series B$50M5 new3 returning
- Qiming Venture Partners
- Cormorant Asset Management
- Omega Funds
- Bay City Capital
- EcoR1 Capital
- Pappas Capital
- Aju IB
- Morningside Venture/ Cowen
Reported by FinSMEsSEC filing: $50M sold, first sale Jun 2017
Jun 2015
Series A$23M6 new
From a historical funding recordSEC filing: $28M sold, first sale Jun 2015

Founders and team

From Kezar Life Sciences's own website and the SEC filings it signed: 7 on the team.

Kevin TangChair of the Board and Chief Executive Officer
Michael HearneChief Financial Officer
Ryan ColeChief Operating Officer
Stew KrollChief Development Officer
Thomas WeiChief Scientific Officer
Christopher J KirkExecutive Officer, Directori
John F FowlerExecutive Officer, Directori

On the board, as filediBihua J ChenFranklin J BergerGerald J ChanJean-Pierre J SommadossiMichael J Kauffman

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2015Series B2017Round2022

Cormorant Asset Management

Omega Funds

Qiming Venture Partners

EcoR1 Capital

Bay City Capital

Aju IB Investment

Pappas CapitalMorningside Ventures9W Capital ManagementAju IB

Everyone who backed them

Cormorant Asset ManagementPrivate equity3rounds

Omega FundsVC firm3rounds

Qiming Venture PartnersVC firm2rounds

EcoR1 CapitalPrivate equity2rounds

Bay City CapitalVC firm1round

Aju IB InvestmentVC firm1round

Pappas CapitalVC firm1round

Morningside VenturesVC firm1round

9W Capital ManagementVC firm1round

Aju IBno record of our own yet1round

Morningside Venture/ Cowenno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Kezar Life Sciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Solasta VenturesVC firmPer its own site

Quick answers about Kezar Life Sciences

Who invested in Kezar Life Sciences?

Kezar Life Sciences's investors include Cormorant Asset Management, Omega Funds, Qiming Venture Partners, EcoR1 Capital and Bay City Capital, and 6 more on record.